TheProfitWatch

MTNB - Matinas BioPharma Holdings, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.87 0.03 (1.6%) --- --- --- --- 0.03 (1.6%) 0.0 (0.0%) 0.0 (0.0%)

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.03
Diluted EPS:
-1.03
Basic P/E:
-1.8447
Diluted P/E:
-1.8447
RSI(14) 1m:
100.0
VWAP:
1.9
RVol:

Events

Period Kind Movement Occurred At

Related News